California-based AN2 Therapeutics Inc, a biopharmaceutical company focused on infectious diseases, has raised $12 million in Series A financing. Mountain Group Partners led the round with participation from Adjuvant Capital, Brii Biosciences and BioRock Ventures.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.